Nice to see you again. A spot of rain is falling on the Pharmalot corporate campus this morning, but our spirits are sunny. We hope your outlook remains upbeat, as well. To keep things moving in the right direction, here are a few items to jumpstart the day. Have a good one and stay in touch...
Pfizer To Restructure Irish Operations (RTE News)
Scotland Offers New Drug Guidance For NHS Boards (PharmaTimes)
Pfizer Settles Neurontin Suit Over Minister's Death (Bloomberg News)
Pfizer And Washington University Strike Drug Deal (St. Louis Post-Dispatch)
Icahn Doubles Genzyme Stake (Reuters)
2 Comments
Dissolution of the European Union would be a boon to the pharmaceutical industry since each country would then be free to negotiate prices with drug manufacturers and not have to worry about political pressure from fellow EU member nations.
If a company that manufactures a Class III medical device was given Conditions of Approval in their approval document, and then 3 years after this device has already been sold and implanted in many patients turns around and submits a proposal to the FDA to have those COA changed, is that legal? Does that company still deserve to be protected under Reigel vs. Medtronics?